NASDAQ: SAVA
Cassava Sciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for SAVA

Based on 1 analyst offering 12 month price targets for Cassava Sciences Inc

Min Forecast
$2.00-0.5%
Avg Forecast
$2.00-0.5%
Max Forecast
$2.00-0.5%

Should I buy or sell SAVA stock?

Based on 1 analyst offering ratings for Cassava Sciences Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SAVA's forecast from analysts indicates a "Hold", our proven Zen Rating quant model rates SAVA as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their SAVA stock forecasts and price targets.

SAVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-25

1 of 1

Forecast return on equity

Is SAVA forecast to generate an efficient return?

Company
N/A
Industry
164.98%
Market
89.42%

Forecast return on assets

Is SAVA forecast to generate an efficient return on assets?

Company
N/A
Industry
43.44%

SAVA earnings per share forecast

What is SAVA's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.55

SAVA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SAVA$2.01$2.00-0.50%Hold
XBIT$3.18N/AN/A
VXRT$0.43$2.00+368.38%Strong Buy
IOBT$1.49$12.00+705.37%Buy
TNYA$0.61$8.60+1,305.23%Strong Buy

Cassava Sciences Stock Forecast FAQ

Is Cassava Sciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SAVA) stock is to Hold SAVA stock.

Out of 1 analyst, 0 (0%) are recommending SAVA as a Strong Buy, 0 (0%) are recommending SAVA as a Buy, 1 (100%) are recommending SAVA as a Hold, 0 (0%) are recommending SAVA as a Sell, and 0 (0%) are recommending SAVA as a Strong Sell.

If you're new to stock investing, here's how to buy Cassava Sciences stock.

What is SAVA's earnings growth forecast for 2025-2025?

(NASDAQ: SAVA) Cassava Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.81%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.76%.

Cassava Sciences's earnings in 2025 is -$72,788,000.

In 2025, SAVA is forecast to generate -$26,569,343 in earnings, with the lowest earnings forecast at -$26,569,343 and the highest earnings forecast at -$26,569,343.

What is SAVA's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SAVA) forecast ROE is N/A, which is considered weak.

What is SAVA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SAVA price target, the average SAVA price target is $2.00, with the highest SAVA stock price forecast at $2.00 and the lowest SAVA stock price forecast at $2.00.

The Wall Street analyst predicted that Cassava Sciences's share price could fall to $2.00 by Mar 25, 2026. The average Cassava Sciences stock price prediction forecasts a potential downside of 0.5% from the current SAVA share price of $2.01.

What is SAVA's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: SAVA) Cassava Sciences's current Earnings Per Share (EPS) is -$1.53. In 2025, SAVA's EPS is forecast to hit -$0.55 (min: -$0.55, max: -$0.55).

What is SAVA's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SAVA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 43.44%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.